Merck & Co., Inc. (MRK)
108.83
-2.14
(-1.93%)
USD |
NYSE |
Jan 16, 16:00
109.18
+0.35
(+0.32%)
After-Hours: 20:00
Merck Research and Development Expense (Quarterly): 3.552B for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen, Inc. | 1.90B |
| Gilead Sciences, Inc. | 1.334B |
| Regeneron Pharmaceuticals, Inc. | 1.338B |
| Cidara Therapeutics, Inc. | 35.53M |
| Moderna, Inc. | 749.00M |